Zdrowie i gospodarka · 27/08/2020

FDA Releases Draft Guidance for Evaluating Cancer Drugs in Patients with Central Nervous System Metastases

The FDA has published a draft guidance document outlining recommendations for clinical trials of cancer drugs targeting patients with CNS metastases from solid tumors, with the goal of supporting product labeling claims of antitumor activity in these patients.